BioWorld. Link to homepage.

Clarivate
  • BioWorld
  • BioWorld Science
  • BioWorld Asia
  • Data Snapshots
    • Biopharma
    • Medical technology
    • Infographics: Dynamic digital data analysis
    • Index insights
    • NME Digest
  • Special reports
    • Infographics: Dynamic digital data analysis
    • BCI
    • Ebola outbreak
    • Hantavirus
    • Trump administration impacts
    • Med-tech outlook 2026
    • Under threat: mRNA vaccine research
    • BioWorld at 35
    • Biopharma M&A scorecard
    • Bioworld 2025 review
    • BioWorld MedTech 2025 review
    • BioWorld Science 2025 review
    • Women's health
    • China's GLP-1 landscape
    • PFA re-energizes afib market
    • China CAR T
    • Alzheimer's disease
    • Coronavirus
    • More reports can be found here

BioWorld. Link to homepage.

  • Sign In
  • Sign Out
  • My Account
Subscribe
BioWorld - Wednesday, July 22, 2026
Breaking News: Best of BioWorld Science: Q2Breaking News: New research identifies EBV antigen targets for MS therapiesBreaking News: Science fiction realized: BCI tech is here
Home » Topics » BioWorld Science, Hematologic

BioWorld Science, Hematologic
BioWorld Science, Hematologic RSS Feed RSS

3-D presents newest research on protease inhibitors

April 20, 2001

Heterocyclic PGI2 agonists in the Fujisawa pipeline

April 19, 2001

Aventis presents new inhibitors of coagulation factors

April 17, 2001

Berlex/Schering AG discover highly potent nonamidine factor Xa inhibitor with oral bioavailability

April 17, 2001

Nonbenzamidine factor Xa inhibitors from DuPont with excellent in vitro profile and improved PK

April 12, 2001

SR-374: a new DuPont compound with potent and selective anti-factor Xa activity

April 9, 2001

Novel aromatic amidine derivatives from Toa Eiyo useful as antithrombotic agents

April 3, 2001

Replacement of benzamidine with azaindole in Aventis series provides oral factor Xa inhibitors

April 3, 2001

New series of factor Xa inhibitors patented by Cor research group

April 2, 2001

DuPont R&D continues focus on potent, selective and orally active factor Xa inhibitors

April 2, 2001
Previous 1 2 … 331 332 333 334 335 336 337 338 339 … 448 449 Next

Popular Stories

  • Today's news in brief

    BioWorld
    BioWorld briefs for July 21, 2026.
  • News in brief

    BioWorld Asia
    BioWorld Asia briefs for July 21, 2026
  • Red CAR T cell on blue blackground

    To viral or not to viral: In vivo CAR T debates delivery tech

    BioWorld
    The field of cell and gene therapy is moving toward a new phase of scalability and clinical durability, with in vivo chimeric antigen receptor (CAR) T-cell...
  • Click chemistry drug bound to pancreatic cancer cells from mice

    In vivo click ADCs could address tumor heterogeneity

    BioWorld
    Researchers at Washington University in St. Louis have used click chemistry to link a second antibody to a pre-existing antibody-drug conjugate (ADC) in vivo. In...
  • In the clinic for July 17, 2026

    BioWorld
    Clinical updates for biopharma and med tech, including data readouts and publications: AMT, Innocare, Insmed, Syntis, Telo Genomics.
  • BioWorld
    • Today's news
    • Analysis and data insight
    • Clinical
    • Data Snapshots
    • Deals and M&A
    • Financings
    • Medical technology
    • Newco news
    • Opinion
    • Regulatory
  • BioWorld Science
    • Today's news
    • Biomarkers
    • Cancer
    • Conferences
    • Endocrine/metabolic
    • Immune
    • Infection
    • Neurology/psychiatric
    • NME Digest
    • Patents
  • BioWorld Asia
    • Today's news
    • Analysis and data insight
    • Australia
    • China
    • Clinical
    • Deals and M&A
    • Financings
    • Newco news
    • Regulatory
    • Science
  • More
    • About
    • Advertise with BioWorld
    • Archives
    • Article reprints and permissions
    • Contact us
    • Cookie policy
    • Copyright notice
    • Data methodology
    • Infographics: Dynamic digital data analysis
    • Index insights
    • Podcasts
    • Privacy policy
    • Share your news with BioWorld
    • Staff
    • Terms of use
    • Topic alerts
    • Videos
Follow Us

Copyright ©2026. All Rights Reserved. Design, CMS, Hosting & Web Development :: ePublishing